Genomic Valley Biotech reports standalone nil net profit/loss in the September 2017 quarter

Capital Market 

Sales rise 40.00% to Rs 0.14 crore

Genomic Valley Biotech reported no net profit/loss in the quarter ended September 2017 as against net loss of Rs 0.06 crore during the previous quarter ended September 2016. Sales rose 40.00% to Rs 0.14 crore in the quarter ended September 2017 as against Rs 0.10 crore during the previous quarter ended September 2016. ParticularsQuarter EndedSep. 2017Sep. 2016% Var.Sales0.140.10 40 OPM %14.29-60.00 -PBDT0.02-0.05 LP PBT0-0.06 100 NP0-0.06 100

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Mon, November 13 2017. 15:58 IST